Common Skin Cancers Flashcards
Basal cell cancer
Begins in the staratum basale from pluripotent stem cells due to mutations in the hedgehog -> most commonly mutations inactivate PTCH1 (a tumor suppressor gene)
Other mutations may activate Smoothened or Hedgehog
Usually begin in areas exposed to the sun. Grows very slowly and don’t normally metastasize. Can reoccur (35-50% within 5 years)
Actinic Keratosis
Also called intraepidermal neoplasia I -> most common pre-malignant skin legion
Can eventually develop into invasive squamous cell carcinoma
Occur in fair skinned individuals - typically produced by UV radiation. Sunscreen reduced likelihood of getting them.
Treatment options for AK
Cryotherapy
5-flourouracil (anti-neoplastic effect via thymidine synthase)
Imiquimod -> TLR7 agonist
Diclogenac -NSAID, inhibits COX2 -> reduction of prostaglandins
Photodynamic therapy - topical t-aminovulinic acid accumulates in dysplastic cells -> upon exposure to radiation, cell death
Ingenol mebutate - active agent in the sap of Australian plant. How? Idk
Squamous cell carcinoma
Appears as growing lumps, often w/ rough surface or as flat, reddish patches that grow slowly.
Begins in the upper portion of the epidermis. Second most common cutaneous malignancy. Sun exposed skin -> can sometimes begin w/ scars or other injured areas (Marjolin’s ulcer)
More likely to invade fatty tissues beneath the skin.
Squamous cell carcinoma in situ (Bowen’s disease)
Subtype of SCC
Earliest form of squamous skin cancer. Looks like scaly, reddish patches that may be crusted. Major risk factor = too much sun.
Keratoacanthoma
Subtype of SCC
Appear as solitary lesion in sun exposed skin. Develop quickly (6-8 weeks) w/ sizes of 1-3 cm.
Cup-shaped invagination of the epidermis with keratin filled central crater.
Invasive squamous cell carcinoma
Occurs typically as a hyperkeratotic papule w/ variable size and thickness and indistinct margins
Metastasis is more common in lip, external ear, or perineural invasion
Non-melanoma skin cancer (NMSC)
Risk factors: UV light - damages DNA in keratinocytes. Fair skin, Gender (men 2x likely) Chemicals, Radiation, having skin cancer, phototherapy, genetic skin diseases (basal cell nevus syndrome, xeroderma pigmentosum) immunosuppression, HPC, smoking
Some treatments that I didnt talk about earlier:
Curettage - looped blade scares tumor away from ajacent normal skin
Excision - cut off w/ margin
Mohs micrographic - less margin, evaluate
Radiotherapy - radiation duh
Melanoma
About 3% of skin cancer but large majority of skin cancer deaths
Can arise from previous nevus, but 70% are de novo
ABCD’s. Ugly duckling rule. If neglected, tumor invasion can get deeper.
Nodular melanoma -> does not have a macular or plaque phase and presents as black or blue papule or nodule
Men: upper back, legs on women. Family history, presence of numerous acquired nevi, or history of blistering sunburns.
Lentigo maligna melanoma and acral lentiginous melanoma
Not correlated w/ intense intermittent sun exposure
Lentigo maligna -> 5% of all melanomas, seen at sites of max sun exposure.
Acral lentiginous -> 3-8% of all melanomas, arise in the volar skin of the palms or soles and the nailbeds. (most common melanoma in not whites)
Breslow depth
MOST IMPORTANT INDICATOR OF PROGNOSIS FOR ALL SUBTYPES OF MELANOMA
Is the maximal thickness of tumor invasion measured by ocular micrometer (recorded in mm w/ less than 1.0 good, thicker than 4mm bad)
Clark level
describes how far a melannoma has penetrated into the skin instead of measuring it. Uses scale of I-V
- the cancer stays in the epidermis (Clark level I)
- the cancer has begun to invade the upper dermis (Clark level II)
- the cancer involves most of the upper dermis (Clark level III)
- the cancer has reached the lower dermis (Clark level IV)
- the cancer has invaded to the subcutis (Clark level V)
Genetics of melanoma
BRAF mutation found in many melanomas -> not inherited, develops during melanoma
Treatment of Melanoma
In situ - wide local excision w/ .5 cm margins
2mm in dept - excised w/ 2 cm margin
Plus greater than 1mm would have sentinel lymph node biopsy
Standard therapy for pts w/ stage 4 and recurrent melanoma
- ) Immunotherapy -> monoclonal antibody (Ipilimumab) that clocks activity of cytotoxic T-lymphocyte antigen 4 -> IL-2 response decent
- ) Signal transduction inducers Venurafenib, selective BRAF mutation (V600E mut)
- ) Chemo
- ) Palliative local therapy